Latest Breaking News On - Schizophrenia international research society - Page 4 : comparemela.com

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) 08.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International

Newron-pharmaceuticals
Schizophrenia-international-research-society
Study-patients-evenamide-newron-treatment-data-from-health-press-release

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 07:06 am EDT

Data from study 014/015, a phase II trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia for up to one year Presentation of study design for potentially.

United-kingdom
Seika
Kyongsang-bukto
South-korea
India
Sri-lanka
Switzerland
Japan
United-arab-emirates
Milan
Lombardia
Italy

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) | Region

MILAN (BUSINESS WIRE) Apr 8, 2024

Canada
Milan
Lombardia
Italy
Switzerland
Seika
Kyongsang-bukto
South-korea
India
United-kingdom
Sri-lanka
United-states

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Dublin
Ireland
Ohio
Italy
Waltham
Massachusetts
Athlone
Westmeath
Washington
American
Sandy-coombs

Bristol Myers reports positive Phase 3 data for schizophrenia drug (NYSE:BMY)

Bristol Myers reports positive Phase 3 data for schizophrenia drug (NYSE:BMY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Italy
Schizophrenia-international-research-society
Annual-congress